BMS-708163_SDS_MedChemExpress
APD668_SDS_MedChemExpress

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:Jul.-18-2017Print Date:Jul.-18-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :APD668Catalog No. :HY-15565CAS No. :832714-46-21.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureNot a hazardous substance or mixture.2.2 GHS Label elements, including precautionary statementsNot a hazardous substance or mixture.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:APD 668; APD–668Formula:C21H24FN5O5SMolecular Weight:477.51CAS No. :832714-46-24. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGThis substance is considered to be non-hazardous for transport.IATAThis substance is considered to be non-hazardous for transport.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。
MedBio_CAS号210830-32-3 N-Me-D-Val-OH·HCl相关物理参数

≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11116
Fmoc-(2-氯苄氧基羰基)赖氨酸
Fmoc-Lys(2-Cl-Z)-OH
133970-31-7
25g
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11078
Fmoc-N-甲基-D-亮氨酸
Fmoc-D-N-Me-Leu-OH
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11079
N-叔丁氧羰基-N-甲基-D-苯丙氨酸二环己胺盐
Boc-D-N-Me-Phe.DCHA
102185-45-5
25g
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11002
2-(叔-丁氧基碳酰胺)-2-苯乙腈
Boc-ON
58632-95-4
25g
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11120
N,N'-双芴甲氧羰基-L-赖氨酸
Fmoc-Lys(Fmoc)-OH
78081-87-5
100g
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11110
Fmoc-L-异亮氨酸
Fmoc-Ile-OH
用于CO_(2)分离的含氨基酸盐促进传递膜研究进展

用于CO_(2)分离的含氨基酸盐促进传递膜研究进展
马玉磊;魏静;银登国;冯超;杜文韬;黄娅;代忠德
【期刊名称】《膜科学与技术》
【年(卷),期】2024(44)2
【摘要】膜分离法由于其高度模块化、占地面积小、化学排放低或无化学排放和易于操作等优势,被广泛认为是有前途的CO_(2)分离技术.然而,对于气体分离,大多数聚合物膜遵循溶解-扩散机制,因此需要在气体渗透性和选择性之间进行权衡,使CO_(2)分离膜在工业应用中受到限制.而促进传递膜被认为是克服这一限制的有效解决方案.本文综述了用于CO_(2)捕集的含氨基酸盐促进传递膜的研究进展,并针对目前存在的问题,对未来含氨基酸盐的促进传递膜的发展方向提出了建议.
【总页数】12页(P165-176)
【作者】马玉磊;魏静;银登国;冯超;杜文韬;黄娅;代忠德
【作者单位】四川大学建筑与环境学院;国家烟气脱硫工程技术研究中心;四川省碳中和技术创新中心;四川大学碳中和未来技术学院;东方电气集团东方锅炉股份有限公司;成都信息工程大学资源与环境学院
【正文语种】中文
【中图分类】TQ028;TQ31
【相关文献】
1.基于促进传递机理的一氧化碳分离膜研究进展
2.氨基酸离子液体/Pebax膜的制备及CO_(2)分离测试
3.陶瓷碳酸盐双相膜分离CO_(2)的研究进展
4.沸石膜在分
离烟气中CO_(2)的挑战:沸石与载体间结合力研究进展5.UiO-66-NH_(2)/聚醚酰亚胺中空纤维膜的制备及其用于CO_(2)分离的研究
因版权原因,仅展示原文概要,查看原文内容请购买。
超高效液相色谱-串联质谱法测定人血浆中精氨酸及衍生物含量

超高效液相色谱-串联质谱法测定人血浆中精氨酸及衍生物含量田晔;江骥;胡蓓;薛金萍;王洪允【摘要】建立了超高效液相色谱-串联质谱(UPLC-MS/MS)法同时测定使用艾普拉唑后人血浆中二甲基精氨酸(ADMA)、对称二甲基精氨酸(SDMA)、单甲基精氨酸(NMMA)、瓜氨酸(Cit)和L-精氨酸(L-Arg)的浓度.采用HILIC亲水相互作用色谱和非衍生化的蛋白沉淀法进行分离分析,色谱柱选取Waters Atlantic HILIC柱(2.1 mm×50 mm×3μm),流动相由乙腈(含0.5%乙酸和0.025%三氟乙酸)-水(含0.5%乙酸和0.025%三氟乙酸)(85:15,v/V)组成,流速0.25 mL/min.采用多反应离子监测(MRM)模式,以电喷雾离子源(ESI)正离子方式检测.结果显示,ADMA、SDMA、NMMA、L-Arg和Cit的线性关系良好,相关系数r均大于0.994 0;ADMA、SDMA和NMMA的线性范围为0.1~5 mmol/L,L-Arg和Cit的线性范围为10~250 mmol/L;5种氨基酸的日内、日间精密度均小于15%,准确度在85%~115%之间.该方法快速、简便、灵敏,可为相关疾病的临床诊断提供一种高效的检测手段.【期刊名称】《质谱学报》【年(卷),期】2016(037)005【总页数】7页(P446-452)【关键词】超高效液相色谱-串联质谱(UPLC-MS/MS);艾普拉唑;蛋白沉淀法;亲水性色谱【作者】田晔;江骥;胡蓓;薛金萍;王洪允【作者单位】福州大学化学学院,福建省功能材料工程研究中心,福建省光动力治疗药物与诊疗工程技术研究中心,福建福州350108;中国医学科学院北京协和医院临床药理中心,北京100730;中国医学科学院北京协和医院临床药理中心,北京100730;中国医学科学院北京协和医院临床药理中心,北京100730;福州大学化学学院,福建省功能材料工程研究中心,福建省光动力治疗药物与诊疗工程技术研究中心,福建福州350108;中国医学科学院北京协和医院临床药理中心,北京100730【正文语种】中文【中图分类】O657.63一氧化氮是人体重要的信使分子,L-精氨酸(L-Arg)在一氧化氮全酶(NOS)的催化下,产生一氧化氮(NO)和瓜氨酸(Cit)[1-2]。
乙酰胺 安全技术说明书

乙酰胺安全技术说明书页码 1 / 9生效日期 02-Sep-2010修订日期 06-Mar-2018版本 1ALFAAA12589根据G B /T 16483-2008, G B /T 17519-2013一 化学品及企业标识产品描述:乙酰胺Product Description:目录编号同义字化学文摘编号(C A S N o .)分子式供应者紧急电话号码电子邮件地址推荐用途不建议的用途二 危险性概述物质或混合物的分类 致癌性类别2标签元素应急综述怀疑致癌. 吸湿的.物理状态固体外观白色气味强烈AcetamideA12589Acetic Acid Amide;Ethanamide;Methanecarboxamide.60-35-5C2 H5 N O上海齐奥化工科技有限公司上海浦东新区环科路515号1号楼910室紧急电话号码+8621-50396381传真:+8621-50396382+86 21-50940938邮件地址:产品安全部门。
实验室化学品.无资料。
警示语警告危害声明H351-怀疑致癌防范说明预防P201-使用前获特别指示P202-在明白所有安全防范措施之前请勿搬动P281-按要求使用个人防护设备响应P308+P313-如接触到或有疑虑:求医/就诊。
储存P403-存放在通风良好的地方处置P501-处置内装物/容器按照可的废弃物处理场物理和化学危害吸湿性.健康危害怀疑致癌.环境危害没有包含对环境有危险的物质或者在废水处理厂不能被降解的物质。
.由于其水溶性,可能在环境中迁移.产品溶于水,在水系统中可能会蔓延.其他危害无可用信息三 成分/组成资料组分化学文摘编号(C A S N o.)重量百分含量乙酰胺60-35-5>95四 急救措施一般建议如果症状持续,请联络医师.眼睛接触立即用大量清水冲洗至少15分钟以上,包括眼皮下面.就医治疗.皮肤接触立即以大量清水冲洗至少 15分钟.如果皮肤刺激持续,请联络医师.吸入转移到新鲜空气处。
BMS-708163 (Avagacestat)_γ分泌酶抑制剂_1146699-66-2_Apexbio

Store at -20°C
For obtaining a higher solubility , please warm the tube at 37°C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.
ApexBio Technology
Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
靶点 :
Proteases
信号通路:
Gamma Secretase
产品描述:
特别声明
产品仅用于研究,
不针对患者销售,望谅解。
每个产品具体的储存和使用信息显示在产品说明书中。ApexBio 产品在推荐的条件下是稳定 的。产品会根据不同的推荐温度进行运输。许多产品短期运输是稳定的,运输温度不同于长 期储存的温度。我们确保我们的产品是在保持试剂质量的条件下运输的。收到产品后,按照 产品说明书上的要求进行储存。
产品说明书
化学性质
产品名: Cas No.: 分子量: 分子式:
产品名: BMS-708163 (Avagacestat) 修订日期: 6/30/2016
BMS-708163 (Avagacestat) 1146699-66-2 520.88 C20H17ClF4N4O4S
化学名: SMILES: 溶解性: 储存条件: 一般建议:
双重敏感mPEG-PDPA-P(AAm-co-AN)_聚合物自组装体的药物递送

功 能 高 分 子 学 报Vol. 36 No. 1 58Journal of Functional Polymers2023 年 2 月文章编号: 1008-9357(2023)01-0058-11DOI: 10.14133/ki.1008-9357.20220322001双重敏感mPEG-PDPA-P(AAm-co-AN)聚合物自组装体的药物递送宋 佳, 张紫薇, 张 婕, 秦飞扬, 徐首红(华东理工大学化学与分子工程学院, 结构可控先进功能材料及其制备教育部重点实验室, 上海 200237)摘 要: 设计合成了一种新型两亲性三嵌段ABC聚合物聚乙二醇单甲醚-聚甲基丙烯酸二异丙胺基乙酯-聚(丙烯酰胺-co-丙烯腈)(mPEG-PDPA-P(AAm-co-AN))。
该聚合物具有pH敏感嵌段PDPA和温度敏感嵌段P(AAm-co-AN),临界溶解温度(UCST)较高,且可以通过改变单体比例来调节UCST。
在室温、中性环境下,该聚合物通过自组装形成刺激响应型胶束,可用于抗肿瘤药物的控释研究。
温度升高诱导聚合物胶束向不对称囊泡结构转变,pH降低促使聚合物形成更加松散的胶束。
在体外释药探究中,聚合物胶束对亲水药物阿霉素(DOX)和疏水药物槲皮素都具有良好的载药效果,在37 ℃、pH=7.4的条件下泄漏量低,随着温度升高和pH降低,胶束释放药物的速率和释放量明显增加。
关键词: 三嵌段聚合物;聚合物胶束;温度/pH双重响应;药物控释;自组装;药物递送中图分类号: O648.2 文献标志码: ASelf-Assembly of Dual-Sensitive mPEG-PDPA-P(AAm-co-AN) forDrug DeliverySONG Jia, ZHANG Ziwei, ZHANG Jie, QIN Feiyang, XU Shouhong(Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University ofScience and Technology, Shanghai 200237, China)Abstract:Poly(ethylene glycol) monomethyl ether-poly(2-diisopropylaminoethyl methacry-late)-poly(acrylamide-co-acrylonitrile) (mPEG-PDPA-P(AAm-co-AN)), a novel amphiphilic triblock ABC polymer, was designed and synthesized. This polymer was prepared by atom transfer radical polymerization (ATRP) and reversible addition-fragmentation chain transfer polymerization (RAFT). When pH changes, PDPA undergoes a hydrophilic-hydrophobic transition. Therefore, the polymer has pH-responsivity with a pH-sensitive point at pH 6.53. The P(AAm-co-AN) fragment forms hydrogen bonds at low temperature. At high temperature, hydrogen bonds are formed between the polymer chains and water molecules so that the polymer mPEG-PDPA-P(AAm-co-AN) has a high critical solution temperature (UCST). By varying the monomer ratios of acrylamide (AAm) to acrylonitrile (AN) and the concentration of the solution, polymers with different UCSTs can be收稿日期: 2022-03-22基金项目: 国家自然科学基金(22078087)作者简介: 宋 佳(1997—),女,硕士生,主要研究方向为智能药物载体设计与合成。
BMS-708163_1146699-66-2_DataSheet_MedChemExpress

Product Name:BMS-708163CAS No.:1146699-66-2Cat. No.:HY-50845Product Data SheetMWt:520.89Formula:C20H17ClF4N4O4S Purity :>98%Solubility:DMSO ≥100mg/mL WaterMechanisms:Biological Activity:Avagacestat (BMS-708163)is a potent selective orally bioavailable -secretase inhibitor of APathways:Neuronal Signaling; Target:γ-secretase <1.2mg/mL Ethanol ≥7.5mg/mLAvagacestat (BMS-708163) is a potent, selective, orally bioavailable γ-secretase inhibitor of A β40 and A β42 with IC50 of 0.3 nM and 0.27 nM, demonstrating a 193-fold selectivity against Notch.IC50 value: 0.3 nM/0.27 nM (A β40/A β42) [1]Target: γ-secretase in vitro: BMS-708163 exhibits weaker selectivity for inhibition of Notch processing with 193-fold IC50value [1]. BMS-708,163 binds directly to the presenilin-1 N-terminal fragment and that binding can be challenged by other pan-GSIs, but not by γ-secretase modulators. Furthermore, BMS-708,163blocks the binding of four different active site-directed GSI photoaffinity probes [2].in vivo: Oral administration of BMS-708163 significantly reduces A β40 levels for sustained periods in References:[1]. Gillman KW, et al. Letter Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor. Med Chem Lett, 2010, 1 (3), 120–124.brain, plasma, and cerebrospinal fluid in rats and dogs. BMS-708163 has no dose-limiting effects in dogs (3 mg/kg during 6 months), with ...,,(),[2]. Crump CJ, et al. BMS-708,163 targets presenilin and lacks notch-sparing activity. Biochemistry.2012 Sep 18;51(37):7209-11.Caution: Not fully tested. For research purposes onlyMedchemexpress LLC18W i l k i n s o n W a y , P r i n c e t o n , N J 08540,U S AE m a i l : i n f o @m e d c h e m e x p r e s s .c o m W e b : w w w .m e d c h e m e x p r e s s .c o m。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:May-24-2017Print Date:May-24-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :BMS-708163Catalog No. :HY-50845CAS No. :1146699-66-21.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureGHS Classification in accordance with 29 CFR 1910 (OSHA HCS)Acute toxicity, Oral (Category 4),H302Acute aquatic toxicity (Category 1),H400Chronic aquatic toxicity (Category 1),H4102.2 GHS Label elements, including precautionary statementsPictogramSignal word WarningHazard statement(s)H302 Harmful if swallowed.H410 Very toxic to aquatic life with long lasting effects.Precautionary statement(s)P264 Wash skin thoroughly after handling.P270 Do not eat, drink or smoke when using this product.P273 Avoid release to the environment.P301 + P312 IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell.P330 Rinse mouth.P391 Collect spillage.P501 Dispose of contents/ container to an approved waste disposal plant.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:Avagacestat; BMS708163; BMS 708163Formula:C20H17ClF4N4O4SMolecular Weight:520.88CAS No. :1146699-66-24. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance White to off-white (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGUN number: 3077Class: 9Packing group: IIIEMS-No: F-A, S-FProper shipping name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S.Marine pollutant: Marine pollutant.IATAUN number: 3077Class: 9Packing group: IIIProper shipping name: Environmentally hazardous substance, solid, n.o.s.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。